Coronary disease & ACSGuideline or statement
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis
- Clinical consensus statement
Recommendations
As issued by the authors
Increased awareness of sex-specific risks and biases in acute coronary syndrome (ACS) management, with a focus on sex-specific bleeding mitigation strategies, antithrombotic management in special conditions (e.g., MI with non-obstructive coronary arteries), and barriers to female representation in CV trials
Original publication
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis. Eur Heart J. Published 20 May 2025. doi:10.1093/eurheartj/ehaf352
Summarised from the published abstract; every number is checked against it